UPDATE 8/21/2020 – COVID-19: Keeping Up With A Moving Target

Arron Berry, RN, BSN, CCRN, PHRN, CFRN provides an update on proning and COVID-19. Topics: *Evidence showing benefits of proning *COVID-19 ARDS lessons learned *Proning in non-intubated COVID-19 patients *Johns Hopkins proning team *Complications from proning

Clinic Insight — Managing Chronic MS Symptoms


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Successful management of multiple sclerosis has gone beyond slowing disease progression and preventing relapses. Improving patients’ health-related quality of life by recognizing and addressing the pervasive chronic symptoms of the disease — spasticity, fatigue, depression, cognitive dysfunction — has become increasingly important. In this eMultipleSclerosis Review Podcast, Dr. Bardia Nourbakhsh from the Johns Hopkins School of Medicine provides clinical insight into reducing the disease burden of these common symptoms. 

UPDATE 8/14/2020 – COVID-19: Keeping Up With A Moving Target

Carrie Outten, MSN, RN, CCRN, ACCNS-AG & Sheila Miranda, RN, MS, CCRN discuss upskilling RNs during the COVID-19 pandemic. Topics: *Progressive care to ICU RN *Training, education, and support *Biggest challenges to upskilling *Maintaining ICU-level competency

UPDATE 8/7/2020 – COVID-19: Keeping Up With A Moving Target

Precious McDonald, RN discusses transport issues during a pandemic. *Logistics: team, equipment, and oxygen consumption *Accessing supplies and medications *Challenges for the crew *How health care providers are adapting *Resources for additional supplies and personnel

UPDATE 8/5/2020 – COVID-19: Keeping Up With A Moving Target

Dr. Auwaerter covers the following topics: *CONVACTA trial of tocilizumab *“Trippple” combination therapy *Vaccine update *Length of infection in asymptomatic COVID-19+ people *Administration of convalescent plasma *Safety of accelerated vaccine development

CFTR, Growth & Liver Disease: A Clinical Perspective


Take our post-test to claim CME credits.

To read a companion newsletter click here.

Where, beyond the lungs, do CFTR modulators provide beneficial effects? Can treatment promote growth in height and BMI? What’s known about CFTR modulator effects on cystic fibrosis-associated liver disease?  

In this eCysticFibrosis Review podcast, Drs. Darla Shores and Anna Reed from the THRIVE Pediatric Intestinal Rehabilitation Center in the Division of Gastroenterology, Hepatology, and Nutrition at the Johns Hopkins Children’s Center take us to the clinic to answer these and other questions crucial to the health of our patients with cystic fibrosis. 

UPDATE 7/31/2020 – COVID-19: Keeping Up With A Moving Target

Dr. Auwaerter interviews Dr. Shmuel Shoham about clinical trial challenges in the era of COVID-19. Topics: *Regulatory, cultural and social challenges *Patient recruitment *Convalescent plasma *Multiple competing studies for inpatients *Problems with COVID+ space for outpatient research